Dosing paradigms, route of administration, and exposure considerations Published in vivo experiments commonly use intraperitoneal (i.p.) administration at 50 mg/kg twice daily for 1228 days in adult male C57BL/6J or ob/ob mice, with cohorts kept at thermoneutrality and studied by indirect calorimetry (CLAMS) and body-composition analyses
Users frequently report noticeable improvements within the first week, with more significant healing occurring over the full treatment cycle
, 36 , 1302-1315, doi: Yang, L., Venneti, S., and Nagrath, D
General questions pertaining to a particular DoD Component and the Component-specific BAA instructions should be submitted in accordance with the instructions given at the beginning of the Component's topics